
Oupeptide
Finnrick has tested 78 samples from Oupeptide across 5 products.
Finnrick Vendor Profile
to
Oupeptide
Tracking 5 products
78 total samples tested
Last test 17 Nov 2025
Take Action
Test My Sample
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Semaglutide | 4 | 5 Aug 2025 | 31 Aug 2025 | |||||
| BPC-157 | 6 | 15 Aug 2025 | 14 Oct 2025 | |||||
| Retatrutide | 29 | 9 Jun 2025 | 17 Nov 2025 | |||||
| Tirzepatide | 38 | 3 Jun 2025 | 14 Nov 2025 | |||||
| PT-141 | 1 | 24 Jul 2025 | 24 Jul 2025 | |||||
Most recent Oupeptide tests
Samples are tested in commercial labs
78
tests
5
products
Scores
AVGMINMAX
First
3 Jun 2025
Last
17 Nov 2025
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 17 Nov 2025 | Retatrutide | View | 30mg | 29.700mg | -1.0% | 99.92% | October 12 2025 | Silver Label / Silver Crimp / Pink Cap | Lab E | Public | |
| 17 Nov 2025 | Retatrutide | View | 30mg | 28.400mg | -5.3% | 99.72% | (no batch ID) | No Label / Silver Crimp / Pink Cap | Lab E | Public | |
| 17 Nov 2025 | Retatrutide | View | 30mg | 29.400mg | -2.0% | 99.82% | September 20 2025 | Silver Label / Silver Crimp / Pink Cap | Lab E | Public | |
| 14 Nov 2025 | Retatrutide | View | 15mg | 22.900mg | +52.7% | 99.80% | (no batch ID) | No Label / Copper Crimp / Clear Cap | Lab G | Public | |
| 14 Nov 2025 | Tirzepatide | View | 30mg | 12.900mg | -57.0% | 99.50% | (no batch ID) | No Label / Copper Crimp / Black Cap | Lab G | Public | |
| 6 Nov 2025 | Retatrutide | View | 20mg | 19.200mg | -4.0% | 99.70% | Sept 2, 2025 | No Label / Silver Crimp / Violet Cap | Lab E | Public | |
| 5 Nov 2025 | Retatrutide | View | 50mg | 56.400mg | +12.8% | 99.80% | September 20 2025 | Silver Label / Silver Crimp / Blue Cap | Lab G | Public | |